Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing

التفاصيل البيبلوغرافية
العنوان: Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing
المؤلفون: Thomas Schön, Jim Werngren, Sven Hoffner, Erik Sturegård, P. Jureen, Kristian Ängeby
المصدر: Antimicrobial Agents and Chemotherapy; Vol 56
Antimicrobial Agents and Chemotherapy
بيانات النشر: AMER SOC MICROBIOLOGY, 2012.
سنة النشر: 2012
مصطلحات موضوعية: Tuberculosis, Genotype, Antitubercular Agents, Microbial Sensitivity Tests, Drug resistance, Gene mutation, Biology, Amidohydrolases, Microbiology, Mycobacterium tuberculosis, 03 medical and health sciences, 0302 clinical medicine, Drug Resistance, Bacterial, Tuberculosis, Multidrug-Resistant, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Pharmacology, 0303 health sciences, 030306 microbiology, Wild type, Reproducibility of Results, Sequence Analysis, DNA, Hydrogen-Ion Concentration, Pyrazinamide, biology.organism_classification, medicine.disease, Virology, 3. Good health, Infectious Diseases, Susceptibility, Mutation, PncA, medicine.drug
الوصف: Pyrazinamide (PZA) is a potent first-line agent for the treatment of tuberculosis (TB) with activity also against a significant part of drug-resistant Mycobacterium tuberculosis strains. Since PZA is active only at acid pH, testing for susceptibility to PZA is difficult and insufficiently reproducible. The recommended critical concentration for PZA susceptibility (MIC, 100 mg/liter) used in the Bactec systems (460 and MGIT 960) has not been critically evaluated against wild-type MIC distributions in clinical isolates of Mycobacterium tuberculosis . Using the Bactec MGIT 960 system, we determined the PZA MICs for 46 clinical M. tuberculosis isolates and compared the results to pncA sequencing and previously obtained Bactec 460 data. For consecutive clinical isolates ( n = 15), the epidemiological wild-type cutoff (ECOFF) for PZA was 64 mg/liter (MIC distribution range, ≤8 to 64 mg/liter), and no pncA gene mutations were detected. In strains resistant in both Bactec systems ( n = 18), the PZA MICs ranged from 256 to ≥1,024 mg/liter. The discordances between pncA sequencing, susceptibility results in Bactec 460, and MIC determinations in Bactec MGIT 960 were mainly observed in strains with MICs close to or at the ECOFF. We conclude that in general, wild-type and resistant strains were clearly separated and correlated to pncA mutations, although some isolates with MICs close to the ECOFF cause reproducibility problems within and between methods. To solve this issue, we suggest that isolates with MICs of ≤64 mg/liter be classified susceptible, that an intermediary category be introduced at 128 mg/liter, and that strains with MICs of >128 mg/liter be classified resistant.
اللغة: English
تدمد: 1098-6596
DOI: 10.1128/AAC.05894-11
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe726010cdb8405195bb772967dc6157Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....fe726010cdb8405195bb772967dc6157
قاعدة البيانات: OpenAIRE
الوصف
تدمد:10986596
DOI:10.1128/AAC.05894-11